- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Mycosis fungoides-type cutanous T-cell lymphoma
- Meeting Date: March 2023
- Public Summary Document (PSD) March 2023 PBAC Meeting - (PDF 1.1MB)
- Public Summary Document (PSD) March 2023 PBAC Meeting - (Word 518KB)
Chlormethine hydrochloride – March 2023
Chlormethine hydrochloride: 0.016% (160 microgram/g) gel; Ledaga®
Last updated
14 July 2023